Back to search results

VibraCool Device for Pain and Opioid Use After ACL Surgery

This study is looking at how well the VibraCool device helps reduce pain and the need for opioid pain medication after anterior cruciate ligament reconstruction (ACLR) surgery. You might be eligible if you've had ACLR surgery. The study will compare the VibraCool device to other methods like cryocompression (Game Ready, Bregs) and standard ice packs. Researchers will measure your pain using a Visual Analog Score (VAS) for the first 7 days after surgery, and track your opioid use for the first 3 days. The goal is to see if VibraCool can help you manage pain with less opioid medication. This study plans to enroll 130 participants, but its current status is unclear.

Study design
This interventional study plans to enroll 130 participants to compare the VibraCool device against cryocompression and standard ice packs.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Pain will be measured for the first 7 days after surgery, and opioid use for the first 3 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06456268

VibraCool Device to Reduce Pain and Opioid Use After Anterior Cruciate Ligament Reconstruction (ACLR)

Recruiting
NAAll AgesInterventionalTreatment
Columbia University
~130 participants
Updated 2026-01-07 on ClinicalTrials.gov
What's tested:VibraCool mechanical stimulation and neuromodulatory therapeutic deviceCryocompression (Game Ready, Bregs) deviceStandard ice packs

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Visual Analog Score (VAS) for pain
Measured over First 7 post-operative days
+1 more outcome measured

Conditions

ACL
Opioid Use
Cryotherapy Effect
Vibration; Exposure
Pain, Postoperative

Explore related trials

Injury of anterior cruciate ligament

NCT06456268

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Columbia University Medical Center

    New York, New Yorkstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Lauren H Redler, MD
[email protected]
212-305-8188
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Underwent ACL reconstruction

Exclusion

Pediatric iliotibial band ACL reconstruction (known to cause significantly more pain)
Non-english speakers (limitations of our study group)

What this trial measures

  • Visual Analog Score (VAS) for painFirst 7 post-operative days

    Scale of 0 to 10, with 10 being the worst pain and 0 being no pain. Will record daily mean VAS pain scores over the first seven post-operative days

  • Opioid useFirst 3 post-operative days

    Percent of patients discontinuing opioid use by or on post-operative day three, compared to those who continue after day three